Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy

NC De Lanerolle, JH Kim, RJ Robbins, DD Spencer - Brain research, 1989 - Elsevier
It has been hypothesized on the basis of animal models of epilepsy that abnormal neural
activity in epilepsy may be related to reorganized neural circuits that facilitate epileptogenesis. …

A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma

EL Mazzaferri, RJ Robbins, CA Spencer… - The Journal of …, 2003 - academic.oup.com
Recent studies have provided new information regarding the optimal surveillance protocols
for low-risk patients with differentiated thyroid cancer (DTC). This article summarizes the …

Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Scanning

RJ Robbins, Q Wan, RK Grewal… - The Journal of …, 2006 - academic.oup.com
Context/Objective: Approximately 15% of thyroid cancer patients develop subsequent metastases.
The clinical course of patients with metastatic thyroid carcinoma is highly variable. We …

[HTML][HTML] Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease

DD Spencer, RJ Robbins, F Naftolin… - … England Journal of …, 1992 - Mass Medical Soc
Background. Parkinson's disease is characterized by the loss of midbrain dopamine
neurons that innervate the caudate and the putamen. Studies in animals suggest that fetal …

Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study

…, R Jaffe, G Joplin, RJ Robbins, J Tyson… - Obstetrical & …, 1986 - journals.lww.com
The effectiveness of bromocriptine in reducing tumor size has not been evaluated
systematically, nor has its use as primary therapy for prolactin-secreting macroadenomas been …

Aging and hypothalamic-pituitary-adrenal response to challenge in humans

TE Seeman, RJ Robbins - Endocrine reviews, 1994 - academic.oup.com
AGING is a multifactorial process that results in heterogeneous patterns of progressive morbidity
and disability (1–3). This complex process is influenced by multiple internal homeostatic …

Prognostic Value of[ 18F]Fluorodeoxyglucose Positron Emission Tomographic Scanning in Patients with Thyroid Cancer

…, H Macapinlac, J Rosai, RJ Robbins - The Journal of …, 2000 - academic.oup.com
Poorly differentiated thyroid cancer lesions often lose the ability to concentrate radioactive [
131 I]iodine (RAI) and exhibit increased metabolic activity, as evidenced by enhanced …

Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software

…, EF Mun, A Barth, RJ Robbins… - Journal of Nuclear …, 2004 - Soc Nuclear Med
Compared with conventional, whole-organ, S-factor-based dosimetry, 3-dimensional (3D),
patient-specific dosimetry better accounts for radionuclide distribution and anatomic patient …

[18F]-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography Localizes Residual Thyroid Cancer in Patients with Negative Diagnostic 131I Whole Body Scans …

…, RD Finn, J Rosai, RJ Robbins - The Journal of …, 1999 - academic.oup.com
Progressive dedifferentiation of thyroid cancer cells leads to a loss of iodine-concentrating
ability, with resultant false negative, whole body radioactive iodine scans in approximately 20…

The evolving role of 131I for the treatment of differentiated thyroid carcinoma

RJ Robbins, MJ Schlumberger - Journal of Nuclear Medicine, 2005 - Soc Nuclear Med
The use of radioactive iodine ( 131 I) for the treatment of thyroid carcinoma has changed
over the past 50 y. These changes are based on increasing awareness of the biophysical …